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Objective: To investigate the VEGF expression and collagen deposition using a latex 
biomembrane as bladder replacement in rabbits.
Materials and Methods: After partial cystectomy, a patch of a non-vulcanized latex 
biomembrane (2 x 2 cm) was sewn to the bladder of rabbits with 5/0 monofilament 
polydioxanone sulfate sutures in a watertight manner. Groups of 5 animals were killed 
at 15, 45 and 90 days after surgery and the bladder was removed. Sections of 5µm were 
cut and stained with picrosirius-red in order to estimate the amount of extracellular 
matrix in the graft. To confirm the presence of VEGF in tissues, protein expression was 
determined by immunohistochemistry.
Results: No death, urinary leakage or graft extrusion occurred in any group. All blad-
ders showed a spherical shape. A progressive reduction in the amount of collagen 
occurred in the graft area and was negatively and linearly correlated with time (p < 
0.001). VEGF expression was higher in grafted areas when compared to controls at 15 
and 45 days after surgery and decreased with time (p < 0.001).
Conclusion: The latex biomembrane as a matrix for partial bladder replacement in rab-
bits promotes temporary collagen deposition and stimulates the angiogenic process.
INTRODUcTION
 Bladder augmentation or replacement has 
the following objectives: reduction of intravesical 
pressure, improvement of urinary continence and 
preservation of urinary tract function. The use of 
gastrointestinal segments remains, even today, the 
technique most frequently employed for this pur-
pose. Augmentation cystoplasty is currently used 
in the treatment of approximately 5% to 25% of 
patients with spina bifida and 13% to 50% of those 
with bladder exstrophy (1). However, the potential 
complications of the use of a portion of the gas-
trointestinal tract to perform augmentation cysto-
plasty have been well characterized. They include 
the development of intestinal and urinary fistulae, 
bladder stones, production of mucus, spontaneous 
bladder perforation, electrolyte imbalance, and car-
cinogenesis (2-4). Autoaugmentation and uretero-
cystoplasty have also been advocated as a solution 
in subsets of patients, but the former does not elicit 
long-term consistent results and the latter depends 
on the presence of a nonfunctioning kidney unit (5).
 Bladder tissue engineering attempts to re-
store native functions of impaired bladders us-
ing biodegradable matrices that serve as templates 
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to guide and orient host tissue regeneration as 
well as harbor environmental signals to promote 
proper tissue growth. Development of biodegrad-
able scaffolds seems to be more appropriate be-
cause they would allow the appropriate time for 
host tissue regeneration with dissolution before 
a foreign body reaction (6). In recent years, the 
porcine small intestinal submucosa (SIS) and the 
bladder acellular matrix graft (BAMG) have been 
used frequently in experimental studies. They act 
as biodegradable materials that allow urothelial 
and smooth muscle regeneration (7). However, the 
SIS and BAMG are xenogeneic materials and need 
advanced technical preparation.
 Previous experimental studies with the 
natural latex biomembrane have proved that it is 
a biodegradable material of easy preparation and 
handling, encouraging tissue neoformation (8,9). 
On this basis, we were interested in investigating 
collagen development and angiogenesis using 
this latex graft. The aim of the present study was 
to investigate vascular endothelial growth fac-
tor (VEGF) expression and collagen deposition 
in bladder replacement using the latex biomem-
brane in rabbits.
MATERIALS AND METHODS
 A total of 15 adult male New Zealand 
rabbits weighting 3.0-3.4 kg underwent bladder 
augmentation with the latex biomembrane. This 
project was approved by the Animal Research 
Committee of our Institution. Groups of five ani-
mals were sacrificed at 15 (group A), 45 (group B) 
and 90 (group C) days after grafting. As controls, 
in each rabbit we excised a full-thickness bladder 
fragment far from the grafted area.
Membrane preparation and Surgical Technique
 Matrix preparation followed a previous-
ly published technique (8,9). The animals were 
anesthetized with an intramuscular injection of 
ketamine (35 mg/kg) and xylazine (5 mg/kg). A 
partial cystectomy (4.0 cm2 - 2.0 x 2.0 cm) was 
performed through a median laparotomy. A latex 
biomembrane patch of the same area was grafted 
to the remaining host bladder with continuous 5/0 
monofilament absorbable polydioxanone sulfate 
suture as described in our previous study (9). After 
surgery, enrofloxacyn (9 mg/kg) was administered 
subcutaneously to all animals daily for 2 days. 
The clinical condition of all animals was evalu-
ated daily from surgery to sacrifice. Animals were 
sacrificed with an intravenous injection of pento-
barbital (60 mg/kg).
Histology and Immunohistochemistry
 Formalin-fixed specimens from the graft-
ed and control areas of the bladder were embed-
ded in paraffin. Sections of 5 µm were cut and 
stained with picrosirius-red in order to estimate 
the amount of extracelullar matrix in the graft.
 An immunohistochemical method for 
VEGF labeling was used to assess angiogenesis. 
Antibody expression was determined by antigen-
antibody reaction followed by development of the 
reaction with a marker visible under the micro-
scope. The immunohistochemical reactions were 
evaluated by light microscopy and immunoreac-
tivity was considered to be positive when stain-
ing was detected in the cell cytoplasm or nucleus. 
The labeling index was determined as the ratio 
between the total number of cells and the number 
of deeply stained cells.
 To confirm the presence of VEGF in tis-
sues, protein expression was determined by im-
munohistochemistry using the VEGFR-3 marker 
(Novocastra®), clone KLT9, at a 1:200 dilution.
 The number of cells with positive staining 
for VEGF was estimated with an Axio Cam camera 
(Zeiss, Germany) and the Axiovision 4.6 software 
(Zeiss, Germany).
 Ten random microscope fields were ex-
amined for histological/immunohistochemical 
evaluation. Cells were counted at 400X magni-
fication by two different pathologists in a blind 
manner. A semi-quantitative analysis was per-
formed and the results are reported as the per-
centage of positive cells in total tissue as shown 
in Table-1.
Statistical Analysis
 Data are reported as medians and range. 
Data regarding the treated and control areas were 
compared by the Wilcoxon test. The relationships 
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RESULTS
 All rabbits survived the procedures and 
were able to void spontaneously after the oper-
ation and no one exhibited urinary leakage. A 
bladder stone was found in one rabbit (6.6%) af-
ter 45 days.
Macroscopic evaluation
 All bladders showed a spherical shape.
 On the 15th postoperative day, blood ves-
between groups were analyzed by analysis of vari-
ance (Kruskal-Wallis test), followed by the Dunn 
test to compare individual pairings. Statistical 
analysis was performed using the GraphPad Prism 
5.00 software (San Diego, CA, USA) and p values < 
0.05 were considered to be statistically significant.
Table 1 - Semi-quantitative scores: percentage of collagen 
deposition and vEGF expression.
Degree Collagen VGEF
Score 0
Score 1(+)
Absent
< 25%
Absent
< 25%
Score 2 (++) 25% to 50% 25% to 50%
Score 3 (+++) 50% to 75% 50% to 75%
Score 4 (++++) > 75% > 75%
sels were visible around the grafted area. After a 
longitudinal incision of the bladder, the presence 
of the latex matrix was easily identified since it 
was almost intact.
 On the 45th day after surgery, the graft 
was almost integrated to the host tissue of the na-
tive bladder. The bladder wall was thicker, mainly 
around the latex membrane. One bladder stone 
(1.5 x 2.0 cm) was observed in one rabbit (6.6%).
 Ninety days after surgery, there was a de-
crease in bladder wall hypertrophy and the graft 
was indistinguishable from the normal host blad-
der on both the inner and outer surfaces (Figure-1). 
There was blood vessel reduction around the 
grafted area.
Microscopic evaluation
 On the 15th postoperative day the luminal 
surface of the latex matrix was still uncovered by 
the urothelium. A fibrovascular reaction was pres-
ent, with rare fibroblasts and a moderate amount 
of inflammatory cells, mainly macrophages. For-
ty-five days after surgery there was diffuse epithe-
lial and smooth muscle hyperplasia on the graft. 
At 90 days there was a reduction of epithelial and 
muscle hyperplasia, and the urothelium was simi-
lar to that of the native bladder. At that time, the 
smooth muscle layers were well organized and 
oriented in a direction similar to that of native 
bladder muscle layers (Figure-2).
Collagen deposition
 The non-grafted areas of the bladder (con-
trol) showed the presence of well compacted col-
Figure 1 - Macroscopic evaluation of the latex biomembrane: (A) spherical architecture (exterior); (B) border between the 
native and new tissues (interior).
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lagen fibers, mainly in the submucosal layer, with 
lower density in the muscle layer. Fifteen days af-
ter the implant there was an overall increase in the 
amount of collagen, with high density on the mus-
cle plans and in the submucosa. Three months after 
the graft, there was a reduction in the amount of 
collagen on the plans corresponding to the muscle 
layers and a tendency to greater concentration in 
the submucosa, similar to control (Figure-3).
 Collagen expression differed significant-
ly between the bladders examined after the latex 
membrane implant and their respective controls 
(Table-1). A progressive reduction in the amount of 
collagen occurred in the graft area and was nega-
tively and linearly correlated with time (p < 0.001) 
(Spearman r = -0.88[-0.69 to -0.97] 95% CI.
VEGF Expression
 Group A animals (15 days) showed intense 
positive labeling for VEGF in undifferentiated cells 
close to the epithelial basement membrane and 
around the fragments of the latex membrane on the 
Figure 3 - Evaluation of collagen. I: control; II: 15 days after the graft; III: 90 days after the graft. Picrosirius-red (Magnification 
400X). c (colagen), E (epithelium). (400X).
Figure 2 - Microscopic evaluation: (A) normal epithelium in non grafted area. (B) 15 days after surgery: note the presence of 
blood vessels (black arrows). (c) 45 days after surgery: epithelium recovering the grafted area (red arrow). (400X). (Hema-
toxylin and Eosin – HE).
IBJU | exPression of vgef and collagen using latex memBrane as Bladder rePlacement
540
bladder wall (Figure-4). The expression of the an-
giogenesis marker differed significantly between the 
experimental group and control, at different times 
(Table-2).
 As also observed for collagen, a progressive 
reduction in VEGF labeling occurred along time (p 
< 0.001) (Spearman r = -0.92[-0.75 to -0.97] 95% CI. 
These data are illustrated in Table-2.
DIScUSSION
 Previous experimental studies with the la-
tex biomembrane have shown that it allows the 
ingrowth of muscle cells and induces a temporary 
inflammatory response, mainly a TH2 lymphocyte 
immune response (9). The ideal material for blad-
der replacement or enlargement should allow the 
Figure 4 - vEGF expression in grafted and non grafted areas over the time. (A) - non grafted area. (B) – grafted area 15 days 
after surgery: higher vEGF expression (black arrows) and remaining latex membrane (red arrows). (c) – grafted area 90 days 
after surgery: note the reduction of vEGF expression. (400x).
Table 2 - Scores of expression of collagen and vEGF in the groups (experimental and control) at different times of evaluation. 
Data are expressed as median and range.
Control Experimental p-value
Collagen deposition
15th day 1 (1-1) 4 (3-4) < 0.001
45th day 1 (1-1) 3 (2-3) < 0.001
90th day 1 (1-1) 2 (1-2) 0.016
VEGF expression
15th day 1 (1-1) 4 (3-4) < 0.001
45th day 1 (1-1) 3 (2-3) < 0.001
90th day 1 (1-1) 2 (1-2) 0.016
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progressive growth of all components of the nor-
mal bladder wall preserving their mechanical and 
functional properties (7,10).
 When present inside the wound, fibro-
blasts act on the synthesis, deposition and remod-
eling of the extracellular matrix (ECM), perform-
ing a new protein synthesis function, especially of 
collagen. The balance between ECM synthesis and 
degradation results in the remodeling of the struc-
ture of connective tissue, a fundamental process 
in wound repair (11). The repair of tissue dam-
aged by surgical resection, by wounds or by other 
chronic lesions can be divided into two processes, 
i.e., regeneration and scarring. The former results 
in the restitution of lost tissues, and the latter in-
volves collagen deposition and scar formation.
 The amount of collagen is an essential 
component of the mechanical properties of blad-
der grafts, conferring strength and maintaining 
the expansibility of the organ. It has been reported 
that the amount of collagen in animals submitted 
to bladder expansion with an acellular graft was 
significantly greater than in bladders expanded 
with a graft previously seeded with autologous 
cells (12), suggesting that the acellular graft used 
(polyglycolic acid) without a previous cell implant 
may lead to a foreign body reaction. Conversely, 
a study assessing the acellular matrix (BAMG) 
revealed that the amount of collagen, especially 
type I, was more marked during the first 15 days 
of graft implant, accompanying the intensity of 
the inflammatory process, and was up to 2.5 times 
greater than in the native bladder used as control. 
However, 3 months after surgery the density of 
collagen fibers in the grafts were the same as in 
the normal bladder (13).
 The tissue responses (cellular and humor-
al) that signal regeneration or scar formation are 
intimately related and may be detected at the be-
ginning of the natural process of injury and in-
flammation. For this reason, this difference should 
not be attributed exclusively to the production 
of collagen or to the inflammatory process (14). 
Animal models have demonstrated that with time 
after grafting there is a tendency to a reduction 
of the process of collagen deposition and to an 
increase of muscle growth, especially in the pres-
ence of stimulation by angiogenic factors (15).
 In any case, there is no doubt that the 
amount of collagen and mainly its behavior along 
time after surgery are important for the analysis of 
tissue response to the graft used. The present study 
using a latex biomembrane demonstrated that, de-
spite the greater amount of collagen in the graft 
area compared to the native bladder during the 
initial period of observation (Group A), there was 
a progressive reduction of collagen negatively and 
linearly correlated with time. These results reduce 
the possibility that the use of a biomembrane graft 
will result in an exclusive healing process with 
fibrosis, rather indicating the occurrence of tissue 
remodeling and regeneration.
 The angiogenesis process may occur by 
migration of endothelial progenitor cells (EPCs) or 
by capillary growth of preexisting vessels. Despite 
a variety of factors that may participate in various 
stages of angiogenesis, VEGF is one of the most 
important factors in adult tissues submitted to 
physiological angiogenesis (proliferative endome-
trium) and to pathological angiogenesis (inflam-
mation, scarring and tissue repair).
 The action of VEGF in the improvement 
of the tissue repair process results from two major 
characteristics, i.e., an increased capillary perme-
ability that permits the arrival of inflammatory 
cells at the site of injury, and a more intense mi-
gration and proliferation of preexisting endothe-
lial cells (16).
 For the appropriate development of native 
tissue, the biodegradable molds must be practically 
impermeable to urine on their luminal surface and 
should permit cellular and vascular growth in the 
portion in contact with native tissue, an essential 
factor for cell survival (17). The neovascularization 
of regenerated tissues is of great importance since 
tissues do not grow more than a few millimeters un-
less they are vascularized (13). A study on humans 
using a graft with a seeding technique for bladder 
expansion has emphasized that neovascularization 
is one of the fundamental factors for appropriate 
cell growth in a biodegradable graft (18).
 In the present study, there was a significant 
amount of vessels in the neoformed tissue, especial-
ly during the early phases of the process of tissue 
repair (first 15 days). A study using bladder regen-
eration with an acellular matrix under stimulation 
IBJU | exPression of vgef and collagen using latex memBrane as Bladder rePlacement
542
with VEGF demonstrated that neovascularization 
is more intense during the first 4 weeks (19), a 
result similar to that obtained here. It is believed 
that rapid generation of a vascular network is im-
perative for providing the blood supply required 
for newly developed tissues (20).
 The comparison of VEGF analysis among 
the three groups presented here demonstrated that 
the expression of this marker of angiogenesis was 
more intense in Group A (15 days), being signifi-
cantly reduced in the 90 day group compared to 
their respective controls. On this basis, we con-
firmed the angiogenic potential of the membrane 
and demonstrated that the process is temporary, 
accompanying the reduction of the inflammatory 
process, important events for the lack of perpetu-
ation of inadequate tissue response to the graft 
used. An explanation for this phenomenon could 
be the intense macrophage activity during the ear-
ly phases of scarring (9), supporting the statement 
that these cells play a controlling role in fibroblast 
proliferation and migration, in matrix formation, 
and in angiogenesis (21,22).
cONcLUSIONS
 This study demonstrates that the latex 
biomembrane as a matrix for partial bladder re-
placement in rabbits promotes temporary collagen 
deposition and stimulates a angiogenic process. 
Future studies mainly with longer time of grafting 
and evaluation of bladder functional properties 
and the detailed immunological response should 
be carried out.
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